Skip to main content
Boryung Corporation logo

Boryung Corporation — Investor Relations & Filings

Ticker · 003850 ISIN · KR7003850005 KO Manufacturing
Open in API
Filings indexed 352 across all filing types
Latest filing 2023-04-11 Regulatory Filings
Country KR South Korea
Listing KO 003850

About Boryung Corporation

https://pharm.boryung.co.kr/eng/index.do

Boryung Corporation is a fully integrated healthcare company founded in 1957. Its core business encompasses the research, development, manufacturing, and global commercialization of pharmaceutical products, with a significant presence in the cardiovascular therapeutic area. The company is distinguished by its pioneering 'Care in Space' (CIS) initiative, which focuses on developing healthcare solutions for humans in extreme environments and leveraging space for new research opportunities. In addition to its pharmaceutical operations, Boryung functions as a healthcare investment company, fostering innovation across the health sector. The company's diverse portfolio includes prescription drugs, over-the-counter products, and a pipeline aimed at addressing future medical needs.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Boryung regarding the submission of a Phase 3 clinical trial application for a new drug (BR1019) to the Korean Ministry of Food and Drug Safety (MFDS). It is a specific disclosure of a material management event (major business matter) related to clinical trial progress. Since it does not fit into specific categories like financial reports, dividends, or share transactions, it falls under the general regulatory filing category.
2023-04-11 Korean
투자판단관련주요경영사항
Regulatory Filings Classification · 100% confidence The document is a regulatory disclosure from Boryung regarding the approval of a Phase 3 clinical trial for a new drug combination (BR1017) by the Korean Ministry of Food and Drug Safety (MFDS). It follows the standard format for 'Major Management Matters' (투자판단 관련 주요경영사항) filings in the Korean market, which are used to disclose material events such as clinical trial approvals. Since it does not fit into specific categories like financial reports, dividends, or M&A, it falls under the general regulatory filing category.
2023-04-07 Korean
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a regulatory filing from Boryung Corporation regarding the extension of a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 연장결정). This type of filing, which details the company's decision to buy back its own shares through a trust, falls under the category of 'Transaction in Own Shares'.
2023-03-31 Korean
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a regulatory filing (major report) regarding the extension of a trust agreement for the acquisition of treasury shares (share buyback). It details the contract period, the purpose of the acquisition, and the current status of treasury shares held by the company. This falls under the category of 'Transaction in Own Shares' (POS), as it specifically concerns the company's decision to manage its own shares through a trust contract.
2023-03-31 Korean
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange regarding the extension of a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 연장결정). This document details the company's decision to buy back its own shares through a trust, which falls under the category of 'Transaction in Own Shares' (POS).
2023-03-31 Korean
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange. It specifically details the extension of a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 연장결정). According to the provided filing definitions, documents related to a company buying back its own shares are classified as 'Transaction in Own Shares' (POS).
2023-03-31 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.